Publication Name	World Journal of Clinical Cases
Manuscript ID	84511
Country	India

Received	2023-03-17 02:30
Peer-Review Started	2023-03-17 02:34
To Make the First Decision
Return for Revision	2023-05-12 01:07
Revised	2023-05-12 14:22
Second Decision	2023-05-17 02:54
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-05-17 07:48
Articles in Press	2023-05-17 07:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-05-26 07:54
Publish the Manuscript Online	2023-06-12 08:16

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers
Manuscript Source	Invited Manuscript
All Author List	Narmadha Rathinasamy, Sathish Muthu and Anand Krishnan
Funding Agency and Grant Number
Corresponding Author	Sathish Muthu, Visiting Professor, MS, N/A, N/A, Department of Orthopaedics, Orthopaedic Research Group, Ramanathapuram, Coimbatore 641045, Tamil Nadu, India. drsathishmuthu@gmail.com
Key Words	Immunotherapy; Neo-adjuvant chemotherapy; Oral cancer
Core Tip	There is a need to potentiate the effect of neo-adjuvant chemotherapy (NACT) in oral cancers. The utilization of immunotherapy to enhance NACT has been shown to reduce metastasis and recurrence. Hence, the concept of low-dose immunotherapy as a potentiator of NACT could be implemented in routine practice. Moreover, low-dose immunotherapy-enhanced NACT helps us understand the predictors of treatment response.
Publish Date	2023-06-12 08:16
Citation	Rathinasamy N, Muthu S, Krishnan A. Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers. World J Clin Cases 2023; 11(17): 3976-3979
URL	https://www.wjgnet.com/2307-8960/full/v11/i17/3976.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i17.3976

Full Article (PDF)	WJCC-11-3976-with-cover.pdf
Full Article (Word)	WJCC-11-3976.docx
Manuscript File	84511_Auto_Edited-JLW.docx
Answering Reviewers	84511-Answering reviewers.pdf
Audio Core Tip	84511-Audio core tip.ogg
Conflict-of-Interest Disclosure Form	84511-Conflict-of-interest statement.pdf
Copyright License Agreement	84511-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	84511-Language certificate.pdf
Peer-review Report	84511-Peer-review(s).pdf
Scientific Misconduct Check	84511-Bing-Fan JR-2.png
Scientific Editor Work List	84511-Scientific editor work list.pdf
CrossCheck Report	84511-CrossCheck report.pdf
CrossCheck Report	84511-CrossCheck.png